ALGS · Aligos Therapeutics Inc
United States · RS rating 34 · As of 2026-11-03
| Price | 4.75 USD |
|---|---|
| 1-day change | +3.3% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 32 / 67 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 12 / 43 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +37.2% |
| Sales growth Q/Q | -77.2% |
| Distance from 52-week high | +64.3% |
| Market cap (USD) | $37.9M |